Puerarin improved STZ-induced diabetic retinopathy by inhibiting the morphological changes of inner and outer nuclear layers via the down-regulation of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor-1α (HIF-1α) expression (Teng et al., 2009). This evidence concerns the gene VEGFA and diabetic retinopathy.